产品封面图

骨保护蛋白/护骨素抗体

收藏
  • ¥1900
  • Biorigin
  • 2025年07月31日
  • WB,
  • Human,Mouse,Rat,Dog,Rabbit,
avatar
  • 企业认证

    点击 QQ 联系

    • 详细信息
    • 文献和实验
    • 技术资料
    • 适应物种

      Human,Mouse,Rat,Dog,Rabbit,

    • 应用范围

      WB,

    • 抗体英文名

      OPG

    • 规格

      100ul

    英文名称 OPG
    中文名称 骨保护蛋白/护骨素抗体
    别    名 MGC29565; OCIF; OPG; Osteoclastogenesis Inhibitory Factor; TNFRSF 11B; TNFRSF11B; TR 1; TR1; Tumor Necrosis Factor Receptor Superfamily Member 11b; TR11B_HUMAN.  

     

    研究领域 肿瘤  细胞生物  免疫学  信号转导  骨髓细胞  
    抗体来源 Rabbit
    克隆类型 Polyclonal
    交叉反应 Human, Mouse, Rat,  (predicted: Dog, Rabbit, )
    产品应用 WB=1:500-2000 ELISA=1:5000-10000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500 (石蜡切片需做抗原修复)
    not yet tested in other applications.
    optimal dilutions/concentrations should be determined by the end user.
    分 子 量 44kDa
    细胞定位 分泌型蛋白 
    性    状 Liquid
    浓    度 1mg/ml
    免 疫 原 KLH conjugated synthetic peptide derived from human OPG:201-300/401 
    亚    型 IgG
    纯化方法 affinity purified by Protein A
    储 存 液 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
    保存条件 Shipped at 4℃. Store at -20 °C for one year. Avoid repeated freeze/thaw cycles.
    PubMed PubMed
    产品介绍 Osteoprotegerin (OPG, or osteoclastogenesis inhibitory factor) is a secretory glycoprotein belonging to TNF receptor superfamily. Acts as decoy receptor for RANKL and thereby neutralizes its function in osteoclastogenesis. Inhibits the activation of osteoclasts and promotes osteoclast apoptosis. Bone homeostasis seems to depend on the local RANKL/OPG ratio. May also play a role in preventing arterial calcification. May act as decoy receptor for TRAIL and protect against apoptosis. TRAIL binding blocks the inhibition of osteoclastogenesis. OPG acts as a soluble factor in the regulation of bone mass and may be beneficial in the treatment of osteoporosis with increased osteoclast activity. OPG consists of 401 amino acids with a molecular weight of 44 kDa as a monomer and 90 kDa as a disulphide-linked dimer.

    Function:
    Acts as decoy receptor for RANKL and thereby neutralizes its function in osteoclastogenesis. Inhibits the activation of osteoclasts and promotes osteoclast apoptosis in vitro. Bone homeostasis seems to depend on the local RANKL/OPG ratio. May also play a role in preventing arterial calcification. May act as decoy receptor for TRAIL and protect against apoptosis. TRAIL binding blocks the inhibition of osteoclastogenesis.

    Subunit:
    Homodimer.

    Subcellular Location:
    Secreted.

    Tissue Specificity:
    Highly expressed in adult lung, heart, kidney, liver, spleen, thymus, prostate, ovary, small intestine, thyroid, lymph node, trachea, adrenal gland, testis, and bone marrow. Detected at very low levels in brain, placenta and skeletal muscle. Highly expressed in fetal kidney, liver and lung.

    Post-translational modifications:
    N-glycosylated. Contains sialic acid residues.
    The N-terminus is blocked.

    DISEASE:
    Defects in TNFRSF11B are the cause of juvenile Paget disease (JPD) [MIM:239000]; also known as hyperostosis corticalis deformans juvenilis or hereditary hyperphosphatasia or chronic congenital idiopathic hyperphosphatasia. JPD is a rare autosomal recessive osteopathy that presents in infancy or early childhood. The disorder is characterized by rapidly remodeling woven bone, osteopenia, debilitating fractures, and deformities due to a markedly accelerated rate of bone remodeling throughout the skeleton. Approximately 40 cases of JPD have been reported worldwide. Unless it is treated with drugs that block osteoclast-mediated skeletal resorption, the disease can be fatal.

    Similarity:
    Contains 2 death domains.
    Contains 4 TNFR-Cys repeats.

    SWISS:
    O00300

    Gene ID:
    4982

    Database links:

    Entrez Gene: 4982 Human

    Omim: 602643 Human

    SwissProt: O00300 Human

    Unigene: 81791 Human



    Important Note:
    This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.

    护骨素又称护骨因子(osteorotegenin,OPG)、骨保护蛋白、破骨细胞生成抑制因子、骨保护素、破骨细胞抑制生成因子(osteoclastogenesis inhibitory factor,OCIF)
    OPG属于TNF受体超家族,主要功能是抑制破骨细胞的分化、成熟破骨细胞的骨吸收活性,并诱导其凋亡。

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    image.png

    image.png

    image.png

    image.png

    image.png

    image.png

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    相关实验
    • 【求助】关于gsk3-beta功能的疑问

      (3)同上。两个磷酸化位点都要做,但是可能在不同的病理条件下,侧重点有所不同,这主要体现在你的论文的讨论中。因此建议实验前多做论文研究,查阅一下别人的发表文章,看看与你的病理模型更相关的是哪个位点。 真爱满行囊 非常感谢你 的回复,现在我遇到的问题是我做出来蛋白总量还有216位点是有变化的,9位因为买的是santa curz的抗体,现在死活做不出来,很头痛,我要说明的问题是他的活性降低,我也看到216位点磷酸化水平降低了,可是现在没有第九位的结果(就是没有办法得到第九

    • 新型光机结合的二维共焦生物芯片扫描仪设计

      扫描仪中,都采用机械式的二维X,Y线性扫描技术实现,即X,Y方向都采用直线驱动器和直线导轨实现往复运动。此类装置,由于驱动系统的频率限制,驱动器的扫描惯性大,使得扫描效率低,分析时间相当长;并且往复行程长,对直线导轨的精度要求相当高。二、光机结合的二维扫描系统为同样实现生物芯片的二维扫描,我们的实验装置设计如图2,采用了振镜和大数值孔径的远心f-è物镜相结合实现X方向扫描,Y方向的运动仍采用直线驱动器和直线导轨实现。 系统中,对于f-è物镜,满足x2fè(è为振镜的摆动角度,f为物镜焦距)的线性

    • 酶标洗板机

      目前自动洗板机应用比较广泛,凡是具有酶联免疫吸附技术(ELISA)的酶反应板均可使用。应用范围有:肿瘤标记物的检测、传染性疾病的检查、人类免疫缺陷病毒(HIV)抗体的检测、沙眼衣原体感染的血清学检查和TORCH感染的血清学检查等。应用ELISA完成这些方面的检测后,使用先进的全自动洗板机进行洗板,以保证测试的准确性和提高实验的可靠性。 自动洗板机是进行酶联免疫实验时,检测各种感染性病毒所必备的设备之一,其作用是通过清洗,实现酶联免疫实验过程中结合相与游离相的分离。当前,酶标洗板

    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥600
    北京百奥莱博科技有限公司
    2025年07月15日询价
    询价
    上海钰博生物科技有限公司
    2026年03月06日询价
    ¥1580
    上海钦诚生物科技有限公司
    2025年07月09日询价
    ¥1000
    上海烜雅生物科技有限公司
    2026年03月09日询价
    询价
    上海研生实业有限公司
    2025年07月11日询价
    骨保护蛋白/护骨素抗体
    ¥1900